Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular CarcinomaMasahito Nakano, Masahiko Kajiwara, Kunitaka Fukuizumi et al.|Oncology|2012Cited by 34
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular CarcinomaHideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu et al.|Cancers|2021Cited by 32
First‐line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective studyShigeo Shimose, Takuji Torimura, Atsushi Hiraoka et al.|Cancer Medicine|2021Cited by 16